Inventor · disambiguated record
Matthew S. Dowling
Also filed as: DOWLING MATTHEW · DOWLING MATTHEW S · DOWLING MATTHEW SCOTT
19 granted patents·7 pending applications·163 citations·filing 2007–2025
94Inventor score
Top patents by PatentIndex Score
26 records- 0198US10851081B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2020·Granted Dec 1, 2020·12 cites·19 claims
- 0297US11512070B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2020·Granted Nov 29, 2022·11 cites·16 claims
- 0397US10208019B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2017·Granted Feb 19, 2019·50 cites·26 claims
- 0497US10071992B2Diacylglycerol acyl transferase 2 inhibitorsPFIZER·Filed 2017·Granted Sep 11, 2018·24 cites·24 claims
- 0596US9809579B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2016·Granted Nov 7, 2017·26 cites·26 claims
- 0694US10669259B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2018·Granted Jun 2, 2020·13 cites·31 claims
- 0791US10174007B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2017·Granted Jan 8, 2019·8 cites·12 claims
- 0889US11034678B2Diacylglycerol acyl transferase 2 inhibitorsPFIZER·Filed 2020·Granted Jun 15, 2021·2 cites·10 claims
- 0988US12319669B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Jun 3, 2025·0 cites·21 claims
- 1088US11866425B2Diacylglycerol acyl transferase 2 inhibitorsPFIZER·Filed 2021·Granted Jan 9, 2024·1 cites·10 claims
- 1185US10988463B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2020·Granted Apr 27, 2021·1 cites·8 claims
- 1284US2024140937A1Diacylglycerol Acyl Transferase 2 InhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 1383US10787438B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2020·Granted Sep 29, 2020·1 cites·24 claims
- 1483US2025257052A1Glp-1 receptor agonists and uses thereofPFIZER·Filed 2025·Application pending·0 cites
- 1582US11802121B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2022·Granted Oct 31, 2023·0 cites·20 claims
- 1680US8889730B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Nov 18, 2014·5 cites·5 claims
- 1778US8106077B2Compounds and methods for modulating FXRBELL MICHAEL GREGORY·Filed 2007·Granted Jan 31, 2012·6 cites·9 claims
- 1876US11634410B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2021·Granted Apr 25, 2023·0 cites·18 claims
- 1975US9399626B22-thiopyrimidinonesPFIZER·Filed 2014·Granted Jul 26, 2016·2 cites·6 claims
- 2069US9394285B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Jul 19, 2016·1 cites·6 claims
- 2165US2019106412A1Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2018·Application pending·0 cites
- 2261US2018258081A1Diacylglycerol acyl transferase 2 inhibitorsPFIZER·Filed 2018·Application pending·0 cites
- 2353US9873673B22-thiopyrimidinonesPFIZER·Filed 2016·Granted Jan 23, 2018·0 cites·11 claims
- 2452US2025346567A1Substituted pyridine and phenyl compoundsPFIZER·Filed 2025·Application pending·0 cites
- 2551US2015038484A1Indole and indazole compounds that activate ampkPFIZER·Filed 2014·Application pending·0 cites
- 2650US2022387402A1Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseasesPFIZER·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →